Welcome to LookChem.com Sign In|Join Free

CAS

  • or

222036-27-3

Post Buying Request

222036-27-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

222036-27-3 Usage

Description

7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) is a chemical compound that serves as an intermediate in the synthesis of Imidazolo-oxindole PKR inhibitor C16 (PKR Inhibitor) (P572500). 7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) plays a crucial role in the development of a drug that acts as a selective inhibitor of the enzyme double-stranded RNA-dependent protein kinase (PKR).

Uses

Used in Pharmaceutical Industry:
7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) is used as an intermediate in the synthesis of PKR Inhibitor for its role in developing a drug that selectively inhibits the enzyme double-stranded RNA-dependent protein kinase (PKR). This inhibition has been shown to effectively suppress PKR function in vivo, leading to neuroprotective and nootropic effects in animal studies.
Used in Neuroprotective Applications:
7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) contributes to the development of a drug with neuroprotective properties, as it is an intermediate in the synthesis of a PKR inhibitor. The inhibition of PKR has been linked to the prevention of neuronal cell death and the promotion of overall brain health.
Used in Nootropic Applications:
7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) is also used in the development of nootropic drugs, which are designed to enhance cognitive function and improve memory. The PKR inhibitor, synthesized using 7H-Pyrrolo[2,3-g]benzothiazol-7-one,6,8-dihydro-(9CI) as an intermediate, has demonstrated nootropic effects in animal studies, suggesting its potential use in improving human cognitive abilities.

Check Digit Verification of cas no

The CAS Registry Mumber 222036-27-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,2,0,3 and 6 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 222036-27:
(8*2)+(7*2)+(6*2)+(5*0)+(4*3)+(3*6)+(2*2)+(1*7)=83
83 % 10 = 3
So 222036-27-3 is a valid CAS Registry Number.

222036-27-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6,8-dihydropyrrolo[2,3-g][1,3]benzothiazol-7-one

1.2 Other means of identification

Product number -
Other names 6.8-dihydro-1-thia-3,6-diaza-as-indacen-7-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:222036-27-3 SDS

222036-27-3Relevant articles and documents

Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors

-

, (2008/06/13)

-

Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis

Bramson,Holmes,Hunter,Lackey,Lovejoy,Luzzio,Montana,Rocque,Rusnak,Shewchuk,Veal,Corona,Walker,Kuyper,Davis,Dickerson,Edelstein,Frye,Gampe Jr.,Harris,Hassell

, p. 4339 - 4358 (2007/10/03)

Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor. Crystallographic analysis of the lead compound bound to CDK2 provided the basis for analogue design. A semiautomated method of ligand docking was used to select compounds for synthesis, and a number of compounds with low nanomolar inhibitory activity versus CDK2 were identified. Enzyme binding determinants for several analogues were evaluated by X-ray crystallography. Compounds in this series inhibited CDK2 with a potency ~10-fold greater than that for CDK1. Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 222036-27-3